Skip to content

Blog

Latest articles, insights, and updates from the blog.

167 articles

Contact Low Dose Ketamine

Send corrections, provider questions, or advertising inquiries.

Pharmacokinetics1 min read

Pharmacokinetics of Ketamine: Absorption, Distribution, Metabolism, and Elimination

Learn how ketamine is absorbed, distributed, metabolized, and eliminated across IV, intranasal, oral, sublingual, IM, and subcutaneous routes.

Dosing1 min read

Renal and Hepatic Dose Adjustments for Low-Dose Ketamine

Learn how liver and kidney impairment can affect low-dose ketamine planning, monitoring, recovery, and questions to ask a prescribing clinician.

Dosing1 min read

Defining Sub-Anesthetic Ketamine: Dose Ranges and Therapeutic Windows

Sub-anesthetic ketamine spans 0.1 to 1.0 mg/kg depending on indication. Learn how dose, NMDA receptor occupancy, and route shape each therapeutic window.

Research1 min read

Ketamine, Neuroplasticity, and Brain-Derived Neurotrophic Factor

How does low-dose ketamine drive neuroplasticity? A look at BDNF release, TrkB and mTOR activation, and the synapse rebuilding behind its rapid antidepressant effect.

Research1 min read

Low-Dose Ketamine for Acute Suicidal Ideation: Clinical Evidence

A review of the clinical trial evidence examining low-dose ketamine as an intervention for acute suicidal ideation. This article evaluates randomized controlled trials, naturalistic studies, and emergency department protocols demonstrating ketamine's rapid anti-suicidal effects.

Conditions1 min read

Low-Dose Ketamine for Treatment-Resistant Depression

Learn what research says about low dose ketamine for treatment-resistant depression, including rapid effects, safety monitoring, esketamine, and questions to ask a clinician.

Research1 min read

Rapid-Onset Antidepressant Mechanisms of Low-Dose Ketamine

Low-dose ketamine's rapid-onset antidepressant mechanisms explain why relief begins in hours, not weeks, via NMDA blockade and BDNF-driven synaptic growth.

Research1 min read

Meta-Analyses of Low-Dose Ketamine for Treatment-Resistant Depression

Meta-analyses of low-dose ketamine for treatment-resistant depression show large 24-hour effects and better durability for racemic ketamine than esketamine.

Dosing1 min read

Dose-Response Relationships in Low-Dose Ketamine Therapy

Learn why low dose ketamine therapy does not have one universal dose, how route and treatment goals affect response, and which questions to bring to follow-up.

At Home Monitoring1 min read

Patient Selection Criteria for Low-Dose Ketamine Therapy

Learn how clinicians assess candidates for low dose ketamine therapy, including diagnosis, treatment history, safety screening, practical readiness, and monitoring.